Hubácek J A, Adámková V, Ceska R, Poledne R, Horínek A, Vráblík M
Institute for Clinical and Experimental Medicine, First Medical Faculty, Charles University, Prague, Czech Republic.
Physiol Res. 2004;53(2):225-8.
Animal studies (on transgenic and knock-out mice) and human association analysis assessed the importance of APOAV gene for plasma triglyceride determination. New APOAV missense variants (Val153 --> Met and Cys185 --> Gly) have been detected recently. We have analyzed these variants in 83 unrelated patients with extreme lipid parameters (triglycerides of 20.4+/-2.8 mmol/l and total cholesterol of 10.4+/-3.7 mmol/l) and in a control population group consisting of 2,559 unrelated Caucasians. In patients, the frequency of the Met153 carriers was slightly but not significantly higher (9.64 % vs. 6.49 %) compared to the population sample. This suggested that Val153 Met polymorphism in the APOAV gene does not represent an important risk factor for developing the extreme levels of plasma triglycerides. We did not detect carriers of the Gly185 allele among patients or 420 healthy individuals. We suppose that this variant is probably not present in Caucasian populations
动物研究(针对转基因和基因敲除小鼠)以及人类关联分析评估了载脂蛋白AV(APOAV)基因在血浆甘油三酯测定中的重要性。最近检测到了新的载脂蛋白AV错义变体(缬氨酸153变为甲硫氨酸以及半胱氨酸185变为甘氨酸)。我们在83例具有极端血脂参数(甘油三酯为20.4±2.8毫摩尔/升,总胆固醇为10.4±3.7毫摩尔/升)的无亲缘关系患者以及由2559名无亲缘关系的高加索人组成的对照人群组中分析了这些变体。在患者中,与人群样本相比,甲硫氨酸153携带者的频率略高但无显著差异(9.64%对6.49%)。这表明载脂蛋白AV基因中的缬氨酸153变为甲硫氨酸多态性并非导致血浆甘油三酯达到极端水平的重要危险因素。我们在患者或420名健康个体中均未检测到甘氨酸185等位基因的携带者。我们推测该变体可能在高加索人群中不存在。